RE: Merck published fake journal

["Nawin Gupta" <nawin.gupta@comcast.net>]

Elsevier has been in business for a few hundred years; this is 
not something that serves Elsevier interests and the revenues 
from this journal had to be a pittance.  As we have learned time 
and again, some dumb decisions do get made at functional levels 
that do not represent organizational principles and philosophy. 
Recent case in point - fly over of Air Force One over Statue of 
Liberty in NY for photo ops.

As for the revenues coming from commercial sector, most medical 
publishers get well over 25% of their revenues from commercial 
sector.  We all know of advertising and commercial reprints, not 
to mention premium price paid by commercial entities such as 
pharmaceutical companies for their subscriptions.  We all know of 
publishers, even society publishers, who publish supplements to 
go with peer-reviewed scholarly journals that are fully paid for 
by commercial interests.  I may have some issues with the 
practice, but they serve a useful informational/educational 
purpose; publishers are expected to, and they do, disclose 
commercial sponsorship.

Nawin Gupta